• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据处方药物种类和年龄分析日本医保数据库中抗高血压固定剂量复方制剂的治疗模式。

Treatment patterns of antihypertensive fixed-dose combinations according to age and number of agents prescribed: Retrospective analysis using a Japanese claims database.

机构信息

Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan.

Steel Memorial Yawata Hospital, Kitakyushu, Japan.

出版信息

Geriatr Gerontol Int. 2019 Nov;19(11):1077-1083. doi: 10.1111/ggi.13743. Epub 2019 Aug 21.

DOI:10.1111/ggi.13743
PMID:31436025
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6900198/
Abstract

AIM

To determine the real-world use of fixed-dose combinations (FDC) of antihypertensive agents using data collected from a nationwide medical database of acute hospitals in Japan.

METHODS

We carried out a retrospective analysis of data from the Medical Data Vision database for patients with hypertension who received an antihypertensive drug prescription between April 2014 and March 2015. The prescription rate of antihypertensive FDC were assessed by class, age and according to combinations.

RESULTS

In total, data from 59 867 patients aged 70.0 ± 11.9 years (mean ± SD) were analyzed. Patients were prescribed 1.9 ± 1.0 oral antihypertensive agents (mean ± SD). Overall, 58.6% of patients were prescribed two or more antihypertensive agents, and the most frequently prescribed classes were calcium channel blockers (CCB) and angiotensin II receptor blockers (ARB). As the number of concomitant antihypertensive agents prescribed increased, the prescription rate of a CCB + an ARB FDC decreased, whereas the prescription rate of an ARB + a diuretic FDC increased. This trend was the same regardless of age. Of the 12 222 patients who were prescribed a CCB + an ARB, 26.0% received a FDC. In contrast, of the 922 patients prescribed an ARB + a thiazide diuretic, 80.6% received a FDC. Medium doses of both CCB and ARB agents, and low doses of diuretics were the most frequently prescribed for each class.

CONCLUSIONS

Our analyses show that the real-world use of FDC varies depending on the combination of agent class and the number of prescriptions; the latter was similar regardless of age. Geriatr Gerontol Int 2019; 19: 1077-1083.

摘要

目的

利用来自日本全国急性医院医疗数据库的数据,确定抗高血压药物固定剂量复方制剂(FDC)的实际应用情况。

方法

我们对 2014 年 4 月至 2015 年 3 月间接受抗高血压药物处方的高血压患者的医疗数据库 Vision 进行了回顾性分析。按类别、年龄和组合评估了降压 FDC 的处方率。

结果

共分析了 59867 名 70.0±11.9 岁(平均值±标准差)的患者数据。患者服用 1.9±1.0 种口服降压药(平均值±标准差)。总体而言,58.6%的患者服用了两种或两种以上的降压药,最常开的类别是钙通道阻滞剂(CCB)和血管紧张素 II 受体阻滞剂(ARB)。随着同时服用的降压药数量的增加,CCB+ARB FDC 的处方率降低,而 ARB+利尿剂 FDC 的处方率增加。无论年龄大小,这种趋势都是相同的。在 12222 名服用 CCB+ARB 的患者中,有 26.0%接受了 FDC。相比之下,在 922 名服用 ARB+噻嗪类利尿剂的患者中,有 80.6%接受了 FDC。每类药物中,CCB 和 ARB 药物的中剂量以及利尿剂的低剂量是最常开的。

结论

我们的分析表明,FDC 的实际应用情况因药物类别组合和处方数量而异;后者与年龄无关。老年医学与老年病学国际 2019;19:1077-1083。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e894/6900198/ad6ca651696b/GGI-19-1077-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e894/6900198/478412529776/GGI-19-1077-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e894/6900198/cb7aca965a79/GGI-19-1077-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e894/6900198/54ea67826840/GGI-19-1077-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e894/6900198/ad6ca651696b/GGI-19-1077-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e894/6900198/478412529776/GGI-19-1077-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e894/6900198/cb7aca965a79/GGI-19-1077-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e894/6900198/54ea67826840/GGI-19-1077-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e894/6900198/ad6ca651696b/GGI-19-1077-g004.jpg

相似文献

1
Treatment patterns of antihypertensive fixed-dose combinations according to age and number of agents prescribed: Retrospective analysis using a Japanese claims database.根据处方药物种类和年龄分析日本医保数据库中抗高血压固定剂量复方制剂的治疗模式。
Geriatr Gerontol Int. 2019 Nov;19(11):1077-1083. doi: 10.1111/ggi.13743. Epub 2019 Aug 21.
2
Treatment patterns and adherence to antihypertensive combination therapies in Japan using a claims database.利用索赔数据库研究日本的降压联合治疗模式和用药依从性。
Hypertens Res. 2019 Feb;42(2):249-256. doi: 10.1038/s41440-018-0127-0. Epub 2018 Nov 16.
3
Current use of antihypertensive drugs in Japanese patients with hypertension: Analysis by age group.日本高血压患者的降压药物使用现状:按年龄组分析。
Geriatr Gerontol Int. 2018 Jun;18(6):899-906. doi: 10.1111/ggi.13276. Epub 2018 Mar 6.
4
Frequency and Patterns of Prescribing Antihypertensive Agents in Outpatient Kidney Transplant Recipients Among Six Cities in China from 2011 to 2018.2011 年至 2018 年中国六个城市门诊肾移植受者中抗高血压药物的使用频率和模式。
Clin Ther. 2021 Mar;43(3):602-612. doi: 10.1016/j.clinthera.2021.01.013. Epub 2021 Feb 23.
5
Analysis of second- and third-line antihypertensive treatments after initial therapy with an angiotensin II receptor blocker using real-world Japanese data.利用日本真实世界数据对初始使用血管紧张素II受体阻滞剂治疗后的二线和三线抗高血压治疗进行分析。
Hypertens Res. 2016 Dec;39(12):907-912. doi: 10.1038/hr.2016.96. Epub 2016 Jul 28.
6
[One-year persistence of fixed-dose combinations of angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertensive patients].[高血压患者中血管紧张素转换酶抑制剂与钙通道阻滞剂固定剂量组合的一年持续性]
Orv Hetil. 2019 Mar;160(9):343-348. doi: 10.1556/650.2019.31355.
7
Analysis of Dual Combination Therapies Used in Treatment of Hypertension in a Multinational Cohort.多国队列分析高血压的双联联合治疗。
JAMA Netw Open. 2022 Mar 1;5(3):e223877. doi: 10.1001/jamanetworkopen.2022.3877.
8
Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents.描述了抗高血压药物在服用四种或以上药物的难治性高血压患者中的使用情况。
Hypertension. 2011 Dec;58(6):1008-13. doi: 10.1161/HYPERTENSIONAHA.111.180497. Epub 2011 Oct 31.
9
Current prescription status of antihypertensive drugs with special reference to the use of diuretics in Japan.日本抗高血压药物的当前处方状况,特别提及利尿剂的使用情况。
Hypertens Res. 2017 Feb;40(2):203-206. doi: 10.1038/hr.2016.120. Epub 2016 Sep 1.
10
Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.回顾性分析血管紧张素受体阻滞剂与其他降压药类别在血压管理中的真实世界疗效。
Clin Ther. 2011 Sep;33(9):1190-203. doi: 10.1016/j.clinthera.2011.08.008. Epub 2011 Sep 1.

引用本文的文献

1
Management of Hypertension in the Asia-Pacific Region: A Structured Review.亚太地区高血压管理:系统综述。
Am J Cardiovasc Drugs. 2024 Mar;24(2):141-170. doi: 10.1007/s40256-023-00625-1. Epub 2024 Feb 8.
2
Influence of Hospital Formularies on Outpatient Prescribing Practices: Analysis of the Introduction of a Local Formulary: A Single-Center, 2-Year Follow-Up, Retrospective Cohort Study of a Local Formulary in Japan.医院处方集对门诊处方实践的影响:分析引入本地处方集:一项在日本进行的为期 2 年的单中心回顾性队列研究。
Inquiry. 2022 Jan-Dec;59:469580221087876. doi: 10.1177/00469580221087876.

本文引用的文献

1
Treatment patterns and adherence to antihypertensive combination therapies in Japan using a claims database.利用索赔数据库研究日本的降压联合治疗模式和用药依从性。
Hypertens Res. 2019 Feb;42(2):249-256. doi: 10.1038/s41440-018-0127-0. Epub 2018 Nov 16.
2
2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension.2018年欧洲心脏病学会/欧洲高血压学会动脉高血压管理指南:欧洲心脏病学会动脉高血压管理特别工作组和欧洲高血压学会:欧洲心脏病学会动脉高血压管理特别工作组和欧洲高血压学会。
J Hypertens. 2018 Oct;36(10):1953-2041. doi: 10.1097/HJH.0000000000001940.
3
Effectiveness of fixed-dose combination therapy in hypertension: systematic review and meta-analysis.固定剂量联合疗法治疗高血压的有效性:系统评价与荟萃分析。
Arch Med Sci. 2018 Aug;14(5):1125-1136. doi: 10.5114/aoms.2018.77561. Epub 2018 Aug 13.
4
Medicare Spending on Brand-name Combination Medications vs Their Generic Constituents.医疗保险支出在品牌组合药物与它们的通用成分上的对比。
JAMA. 2018 Aug 21;320(7):650-656. doi: 10.1001/jama.2018.11439.
5
Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical Trial.固定低剂量三联抗高血压药物与常规护理治疗斯里兰卡轻中度高血压患者的血压控制:一项随机临床试验。
JAMA. 2018 Aug 14;320(6):566-579. doi: 10.1001/jama.2018.10359.
6
Prevalence and Correlates of Hypertension among Japanese Adults, 1975 to 2010.1975 年至 2010 年日本成年人高血压的患病率及相关因素。
Int J Environ Res Public Health. 2018 Aug 3;15(8):1645. doi: 10.3390/ijerph15081645.
7
Current prescription status of antihypertensive drugs in Japanese patients with hypertension: Analysis by type of comorbidities.日本高血压患者的降压药物处方现状:按合并症类型分析。
Clin Exp Hypertens. 2019;41(3):203-210. doi: 10.1080/10641963.2018.1465074. Epub 2018 May 21.
8
Current use of antihypertensive drugs in Japanese patients with hypertension: Analysis by age group.日本高血压患者的降压药物使用现状:按年龄组分析。
Geriatr Gerontol Int. 2018 Jun;18(6):899-906. doi: 10.1111/ggi.13276. Epub 2018 Mar 6.
9
Hypertension: New perspective on its definition and clinical management by bedtime therapy substantially reduces cardiovascular disease risk.高血压:通过睡前治疗来定义和临床管理的新视角可显著降低心血管疾病风险。
Eur J Clin Invest. 2018 May;48(5):e12909. doi: 10.1111/eci.12909. Epub 2018 Feb 25.
10
Current prescription status of antihypertensive drugs with special reference to the use of diuretics in Japan.日本抗高血压药物的当前处方状况,特别提及利尿剂的使用情况。
Hypertens Res. 2017 Feb;40(2):203-206. doi: 10.1038/hr.2016.120. Epub 2016 Sep 1.